LETTER
Review: Neurologic Manifestations of HIV Infection
David M. Simpson and
Michele Tagliati
15 February 1995 | Volume 122 Issue 4 | Page 317
In a review article [1], a study by Luft and colleagues [2] about clindamycin therapy for cerebral toxoplasmosis was incorrectly quoted. The dosage for clindamycin should have been 600 mg, four times a day.
1. Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med. 1994; 121:769-85.
2. Luft BJ, Hafner R, Korzun AH, Leport C, Antoniskis D, Bosler EM, et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team. N Engl J Med. 1993; 329:995-1000.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Top
References
Article
